{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:33:36Z","timestamp":1759484016525},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1989,7,1]],"date-time":"1989-07-01T00:00:00Z","timestamp":615254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[1989,7]]},"DOI":"10.1007\/bf02556039","type":"journal-article","created":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T16:17:45Z","timestamp":1170865065000},"page":"209-213","source":"Crossref","is-referenced-by-count":8,"title":["Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures"],"prefix":"10.1007","volume":"45","author":[{"given":"H.","family":"Resch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Willvonseder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02556039_CR1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1126\/science.142.3589.230","volume":"142","author":"JR Cameron","year":"1963","unstructured":"Cameron JR, Sorenson J (1963) Measurement of bone mineral in vivo: an improved method. Science 142:273\u2013279","journal-title":"Science"},{"key":"BF02556039_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0026-0495(84)90187-2","volume":"33","author":"HE Gruber","year":"1984","unstructured":"Gruber HE, Ivey JL, Baylink DJ, Matthews M, Nelp WB, Simson K, Chesnut CH III (1984) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33:295\u2013303","journal-title":"Metabolism"},{"key":"BF02556039_CR3","first-page":"223","volume":"22","author":"G Milhaud","year":"1975","unstructured":"Milhaud G, Talbot JN, Coutris G (1975) Calcitonin treatment of postmenopausal osteoporosis. Evaluation of efficacy by principal components analysis. Biomedicine 22:223\u2013232","journal-title":"Biomedicine"},{"key":"BF02556039_CR4","first-page":"556","volume":"22","author":"S Wallach","year":"1977","unstructured":"Wallach S, Cohn SH, Atkins HL, Ellis KJ, Kohberger R, Aloia JF, Zanzi I (1977) Effects of salmon calcitonin on skeletal mass in osteoporosis. Cur Ther Res 22:556\u2013572","journal-title":"Cur Ther Res"},{"key":"BF02556039_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02556587","volume":"38","author":"GF Mazzuoli","year":"1986","unstructured":"Mazzuoli GF, Passeri M, Gennari C, Minisola S, Antonelli R, Valtorta C, Palummeri E, Cervellin GF, Gonelli S, Francini G (1986) Effects of salmon calcitonin in postmenopausal osteoporosis: a double-blind clinical study. Calcif Tissue Int 38:3\u20138","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"BF02556039_CR6","first-page":"151","volume":"IV","author":"S Serdengecti","year":"1986","unstructured":"Serdengecti S, Serdengecti K, Derman U, Berkada B (1986) Salmon calcitonin in the treatment of bone metastasis. Int J Clin Pharm Res IV (2):151\u2013155","journal-title":"Int J Clin Pharm Res"},{"key":"BF02556039_CR7","volume-title":"Endocrine control of bone and calcium metabolism","author":"A Pencile","year":"1984","unstructured":"Pencile A, Guidobono F, Sibilla V, Netti C (1984) Calcitonin-induced analgesia: role of monoaminergic systems. In: Cohn D, Fujita T, Pottis J Jr, Talmage R (eds) Endocrine control of bone and calcium metabolism. Elsevier Science Amsterdam, vol 8A"},{"key":"BF02556039_CR8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(80)92592-1","volume":"II","author":"R Lindsay","year":"1980","unstructured":"Lindsay R, Hart DM, Forrest C, Baird C (1980) Prevention of spinal osteoporosis in oophorectomized women. Lancet II:1151\u20131153","journal-title":"Lancet"},{"key":"BF02556039_CR9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2362.1980.tb00033.x","volume":"10","author":"C Christiansen","year":"1980","unstructured":"Christiansen C, Christensen MS, MacNair P, Hagen C, Stocklund K, Transbol I (1980) Prevention of postmenopausal bone loss: controlled study (2 years) in 315 normal females. Eur J Clin Invest 10:273\u2013279","journal-title":"Eur J Clin Invest"},{"key":"BF02556039_CR10","unstructured":"Mayo Medical Laboratories Communique (1984) 9:24"},{"key":"BF02556039_CR11","unstructured":"Gergely SM (1982) \u00d6sterreichischer Ern\u00e4hrungsbericht:37\u201338"},{"key":"BF02556039_CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0140-6736(80)90779-5","volume":"I","author":"HP Kruse","year":"1980","unstructured":"Kruse HP, Kuhlenkordt F (1980) Pathogenesis and natural course of primary osteoporosis. Lancet I:280\u2013282","journal-title":"Lancet"},{"key":"BF02556039_CR13","series-title":"Calcitonin 1980","first-page":"237","volume-title":"Chemistry, physiology, pharmacology and clinical aspects","author":"R Agrawal","year":"1981","unstructured":"Agrawal R, Wallch S, Cohn SH, Tessier M, Verch R, Hussain M, Zanzi I (1981) Calcitonin treatment of osteoporosis. In: Pencile A (ed) Chemistry, physiology, pharmacology and clinical aspects. Calcitonin 1980. Excerpta Medica, Amsterdam, pp 237\u2013246"},{"key":"BF02556039_CR14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/jcem-33-5-719","volume":"33","author":"SH Cohn","year":"1971","unstructured":"Cohn SH, Dombrowski CS, Hauser W, Klopper J, Atkins HL (1971) Effects of porcine calcitonin in osteoporosis. J Clin Endocrinol Med 33:719\u2013728","journal-title":"J Clin Endocrinol Med"},{"key":"BF02556039_CR15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/bmj.289.6452.1103","volume":"289","author":"L Nilas","year":"1984","unstructured":"Nilas L, Christiansen C, Rodbro P (1984) Calcium supplementation and postmenopausal bone loss. Br Med J 289:1103\u20131106","journal-title":"Br Med J"},{"key":"BF02556039_CR16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0140-6736(88)91712-6","volume":"I","author":"I MacIntyre","year":"1988","unstructured":"MacIntyre I, Whitehead MI, Banks LM, Stevenson JC, Wimalawansa SJ, Healy MJR (1988) Calcitonin for prevention of postmenopausal bone loss. Lancet I:900\u2013902","journal-title":"Lancet"},{"key":"BF02556039_CR17","first-page":"853","volume-title":"Osteoporosis 1987","author":"C Christiansen","year":"1987","unstructured":"Christiansen C, Riss BJ, Podenphant J, Johansen JS (1987) Intranasal calcitonin in the treatment of postmenopausal osteoporosis In: Christiansen C, Johansen JS, Riss BJ (eds) Osteoporosis 1987. Viborg, N\u00f8rhaven A\/S, pp 853\u2013856"},{"key":"BF02556039_CR18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(87)92619-5","volume":"II","author":"JY Reginster","year":"1987","unstructured":"Reginster JY, Denis D, Albert A, Deroisy R, Lecart MP, Fontaine MA, Lambelin P, Franchimont P (1987) One-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet II:1481\u20131483","journal-title":"Lancet"},{"issue":"2\/3","key":"BF02556039_CR19","first-page":"91","volume":"22","author":"AM Parfitt","year":"1983","unstructured":"Parfitt AM (1983) Calcitonin in the pathogenesis and treatment of osteoporosis. Triangel 22, 2\/3:91\u2013102","journal-title":"Triangel"},{"key":"BF02556039_CR20","series-title":"Calcitonin 1980","first-page":"225","volume-title":"Chemistry, physiology, pharmacology and clinical aspects","author":"A Caniggia","year":"1981","unstructured":"Caniggia A, Lore F, Nuti R, Vattimo A (1981) In: Pencile A (ed) Chemistry, physiology, pharmacology and clinical aspects. Calcitonin 1980. Excerpta Medica, Amsterdam, pp 225\u2013236"},{"key":"BF02556039_CR21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.295.6603.914","volume":"295","author":"Conference Report","year":"1987","unstructured":"Conference Report (1987) Consensus Development Conference: Aalborg, Denmark. Prophylaxis and treatment of osteoporosis. Br Med J 295:914\u2013915","journal-title":"Br Med J"},{"key":"BF02556039_CR22","first-page":"277","volume":"53","author":"LE Nachtigall","year":"1979","unstructured":"Nachtigall LE, Nachtigall RH, Nachtigal RD, Beckmann EM (1979) Estrogen replacement therapy. A 10-year prospective study in relationship to osteoporosis. Obstet Gynecol 53:277\u2013281","journal-title":"Obstet Gynecol"},{"key":"BF02556039_CR23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(81)91848-1","volume":"i","author":"C Christiansen","year":"1981","unstructured":"Christiansen C, Christensen MS, Transbol I (1981) Bone mass in postmenopausal women after withdrawal of oestrogen\/gestagen replacement therapy. Lancet i:459\u2013461","journal-title":"Lancet"},{"key":"BF02556039_CR24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0140-6736(78)90249-0","volume":"i","author":"CJ Hillyard","year":"1978","unstructured":"Hillyard CJ, Stevenson JC, MacIntyre I (1978) Relative deficiency of plasma calcitonin in normal women. Lancet i:961\u2013962","journal-title":"Lancet"},{"key":"BF02556039_CR25","first-page":"237","volume":"i","author":"JC Stevenson","year":"1981","unstructured":"Stevenson JC, Abeyasekera G, Hillyard CJ, Kheng Guek Phang, MacIntyre I (1981) Calcitonin and the calcium-regulatory hormones in postmenopausal women: effect of oestrogens. Lancet i:237","journal-title":"Lancet"},{"issue":"suppl 1","key":"BF02556039_CR26","first-page":"237","volume":"2","author":"KL Sheetz","year":"1987","unstructured":"Sheetz KL, Baker M, Gallegos A, O'Malley BW, Haussler MR (1987) Bone-related cells in culture express putative estrogen receptor mRNA and 125 I-17-estradiol binding. J Bone Min Res 2 (suppl 1):237","journal-title":"J Bone Min Res"},{"key":"BF02556039_CR27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJM198503283121301","volume":"312","author":"AC Arntzenius","year":"1985","unstructured":"Arntzenius AC, Kromhout D, Barth JD, Reiber JHC, Bruschke VG, Buis B, van Gent CM, Kempen Voogd N, Strikwerda S, van der Velde EA (1985) Diet, lipoproteins and the progression of coronary arteriosclerosis. The Leiden intervention trial. N Engl J Med 312:805\u2013811","journal-title":"N Engl J Med"},{"key":"BF02556039_CR28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/bmj.1.6066.935","volume":"1","author":"L Poller","year":"1977","unstructured":"Poller L, Thomson JM, Coope J (1977) Conjugated equine oestrogens and blood clotting. A follow-up report. Br Med J 1:935\u2013936","journal-title":"Br Med J"},{"key":"BF02556039_CR29","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1001\/jama.1980.03310210021018","volume":"244","author":"BS Hulka","year":"1980","unstructured":"Hulka BS, Kaufmann DG, Fowler WC Jr, Grimson RC, Greenberg BG (1980) Predominance of early endometrial cancers after long-term estrogen use. JAMA 244:2419\u20132422","journal-title":"JAMA"},{"key":"BF02556039_CR30","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM198112313052701","volume":"305","author":"MI Whitehead","year":"1981","unstructured":"Whitehead MI, Townsend PT, Pryse-Davis J, Path FRC, Ryder TA, King JB (1981) Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 305:1599\u20131605","journal-title":"N Engl J Med"},{"key":"BF02556039_CR31","first-page":"732","volume":"55","author":"RD Gambull","year":"1980","unstructured":"Gambull RD, Massey FM, Castaneda TA, Ugenas AJ, Ricci CA, Wright JM (1980) Use of progestagen challenge test to reduce the risk of endometrial cancer. Obstet Gynecol 55:732\u2013738","journal-title":"Obstet Gynecol"},{"key":"BF02556039_CR32","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1001\/jama.1979.03290460031015","volume":"241","author":"E Barrett-Connon","year":"1979","unstructured":"Barrett-Connon E, Brown WV, Turner J, Austin M, Criqui MH (1979) Heart disease risk factor and hormone use in postmenopausal women. JAMA 241:2167\u20132169","journal-title":"JAMA"},{"key":"BF02556039_CR33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02556832","volume":"38","author":"D Gonzales","year":"1986","unstructured":"Gonzales D, Ghiringhelli G, Mautalen C (1986) Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women. Calcif Tissue Int 38:71\u201375","journal-title":"Calcif Tissue Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02556039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02556039\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02556039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T22:03:17Z","timestamp":1558303397000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02556039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,7]]}},"alternative-id":["BF02556039"],"URL":"https:\/\/doi.org\/10.1007\/bf02556039","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,7]]}}}